SCHEMBL3063741

SCHEMBL3063741

CC(C)(C)OC(=O)N1CCC(NC(=O)OCCCl)C(O)C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.41
CTSK P43235 1/20 0.38
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37
KMT2A Q03164 1/20 0.37
HSD11B1 P28845 2/20 0.37
CYP2C9 P11712 1/20 0.37
HPGD P15428 1/20 0.37
USP30 Q70CQ3 3/20 0.36
RECQL P46063 1/20 0.36
BTK Q06187 1/20 0.36
PTPN2 P17706 1/20 0.36
PTPN1 P18031 1/20 0.36
PTPN6 P29350 1/20 0.36
GPR119 Q8TDV5 1/20 0.36
KDM4E B2RXH2 1/20 0.35
PKM P14618 1/20 0.35
NR1H2 P55055 1/20 0.35
CDK4 P11802 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3063742 1.00 EPHX1 (0.41) EPHX1CTSKMEN1ALDH1A1MAPT
SCHEMBL27659323 0.85 HSD11B1 (0.48) EPHX1CTSKMEN1ALDH1A1MAPT
SCHEMBL17693025 0.83 EPHX1 (0.44) EPHX1MEN1ALDH1A1MAPTKMT2A
SCHEMBL1220340 0.83 EPHX1 (0.44) EPHX1MEN1ALDH1A1MAPTKMT2A
SCHEMBL17695397 0.83 EPHX1 (0.44) EPHX1MEN1ALDH1A1MAPTKMT2A
SCHEMBL15387793 0.83 EPHX1 (0.44) EPHX1MEN1ALDH1A1MAPTKMT2A
SCHEMBL1220339 0.83 EPHX1 (0.44) EPHX1MEN1ALDH1A1MAPTKMT2A
SCHEMBL3704167 0.83 HSD11B1 (0.43) CTSKMEN1KMT2AHSD11B1
SCHEMBL32684148 0.81 MEN1 (0.47) CTSKMEN1ALDH1A1KMT2AHSD11B1
SCHEMBL16217175 0.80 EPHX1 (0.48) EPHX1MEN1ALDH1A1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100272680-A1 Piperidinyl Cyclic Amido Antiviral Agents BASKARAN SUBRAMANIAN 2010-10-28 US disclosed
WO-2010091411-A1 PIPERIDINYL CYCLIC AMIDO ANTIVIRAL AGENTS GLAXOSMITHKLINE LLC (US) 2010-08-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100272680-A1 Piperidinyl Cyclic Amido Antiviral Agents ZC3HAV1, MAVS, EIF2AK2 EPHX1 4210/4885CTSK 1071/4885MEN1 4774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.